A: The Commission's independence rules apply to audits of financial statements required by SEC rules, except for those required by Rule 3-05 and 3-14 of Regulation S-X and Item 310(c) and (e) of Regulation S-B.
1 The Centers for Disease Control and Prevention (CDC) recommends 2 doses of quadrivalent meningococcal conjugate vaccine for adolescents 11 through 18 years of age.  The first dose should be given at 11 or 12 years of age, followed by a booster dose at age 16.
The U.S. Food and Drug Administration today expanded the approved age range for Menactra, a bacterial meningitis vaccine, to include children ages 2 to 10 years.Meningitis is a serious inflammation of the lining that surrounds the spinal cord and brain.ow there are two vaccines available for children between 2 and 10 years of age who may be at increased risk of meningitis,â said Jesse L. Goodman, M.D., M.P.H., director of FDA's Center for Biologics Evaluation and Research.